NO995591L - Geler med forsinket, langvarig frigjörelse - Google Patents

Geler med forsinket, langvarig frigjörelse

Info

Publication number
NO995591L
NO995591L NO995591A NO995591A NO995591L NO 995591 L NO995591 L NO 995591L NO 995591 A NO995591 A NO 995591A NO 995591 A NO995591 A NO 995591A NO 995591 L NO995591 L NO 995591L
Authority
NO
Norway
Prior art keywords
delayed
gels
long
lasting release
lasting
Prior art date
Application number
NO995591A
Other languages
English (en)
Norwegian (no)
Other versions
NO995591D0 (no
Inventor
Merrill Seymour Goldenberg
Alice C Beekman
Jian Hua Gu
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of NO995591D0 publication Critical patent/NO995591D0/no
Publication of NO995591L publication Critical patent/NO995591L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO995591A 1997-05-16 1999-11-15 Geler med forsinket, langvarig frigjörelse NO995591L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85797397A 1997-05-16 1997-05-16
US91290297A 1997-08-15 1997-08-15
PCT/US1998/010013 WO1998051348A2 (en) 1997-05-16 1998-05-18 Sustained-release delayed gels

Publications (2)

Publication Number Publication Date
NO995591D0 NO995591D0 (no) 1999-11-15
NO995591L true NO995591L (no) 1999-11-15

Family

ID=27127437

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995591A NO995591L (no) 1997-05-16 1999-11-15 Geler med forsinket, langvarig frigjörelse

Country Status (18)

Country Link
EP (1) EP0981374B1 (de)
JP (1) JP2001525826A (de)
KR (1) KR20010012374A (de)
AU (1) AU7491898A (de)
BG (1) BG64860B1 (de)
BR (1) BR9809117A (de)
CA (1) CA2289196C (de)
CZ (1) CZ299180B6 (de)
DE (1) DE69838750T2 (de)
EA (1) EA199901013A1 (de)
ES (1) ES2294814T3 (de)
HU (1) HUP0003393A3 (de)
IL (1) IL132814A0 (de)
NO (1) NO995591L (de)
PL (1) PL199565B1 (de)
SK (1) SK286437B6 (de)
WO (1) WO1998051348A2 (de)
YU (1) YU58599A (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6432449B1 (en) * 1998-05-18 2002-08-13 Amgen Inc. Biodegradable sustained-release alginate gels
AU2003200609B2 (en) * 1998-05-18 2006-02-23 Amgen Inc. Biodegradable sustained-release alginate gels
JP2000256216A (ja) * 1999-03-04 2000-09-19 Meiji Milk Prod Co Ltd ゲル組成物
US7582311B1 (en) 1999-10-15 2009-09-01 Genentech, Inc. Injection vehicle for polymer-based formulations
US7651703B2 (en) 1999-10-15 2010-01-26 Genentech, Inc. Injection vehicle for polymer-based formulations
US20030021848A1 (en) * 1999-11-29 2003-01-30 Johnson Matthew S. Sustained percutaneous delivery of a biologically active substance
FR2823119B1 (fr) * 2001-04-05 2004-02-20 Seppic Sa Adjuvant d'immunite contenant un cation metallique complexe et vaccin le contenant
JP2006505579A (ja) * 2002-10-25 2006-02-16 ファイザー・プロダクツ・インク 懸濁形態でのアリール複素環活性薬物の蓄積製剤
CA2621365C (en) * 2005-05-23 2012-09-04 Natural Alternatives International Compositions and methods for the sustained release of beta-alanine
US20070202186A1 (en) * 2006-02-22 2007-08-30 Iscience Interventional Corporation Apparatus and formulations for suprachoroidal drug delivery
JP5107585B2 (ja) * 2007-01-29 2012-12-26 株式会社 メドレックス 低温充填ゼリー組成物とその製造方法
EP1985286A1 (de) * 2007-04-24 2008-10-29 Biocompatibles UK Limited Mikrokügelchen zur Behandlung von Gehirntumoren
WO2012051575A2 (en) 2010-10-15 2012-04-19 Iscience Interventional Corporation Device for ocular access
WO2014074823A1 (en) 2012-11-08 2014-05-15 Clearside Biomedical, Inc. Methods and devices for the treatment of ocular diseases in human subjects
KR102282973B1 (ko) 2013-05-03 2021-07-27 클리어사이드 바이오메디컬, 인코포레이드 안구용 주사를 위한 장치 및 방법
US10010447B2 (en) 2013-12-18 2018-07-03 Novartis Ag Systems and methods for subretinal delivery of therapeutic agents
WO2015196085A2 (en) 2014-06-20 2015-12-23 Clearside Biomedical, Inc. Variable diameter cannula and methods for controlling insertion depth for medicament delivery
WO2017139375A1 (en) 2016-02-10 2017-08-17 Clearside Biomedical, Inc. Ocular injection kit, packaging, and methods of use
EP3452165A1 (de) 2016-05-02 2019-03-13 Clearside Biomedical, Inc. Systeme und verfahren zur verabreichung eines augenmedikaments
CA3072847A1 (en) 2016-08-12 2018-02-15 Clearside Biomedical, Inc. Devices and methods for adjusting the insertion depth of a needle for medicament delivery
US12090294B2 (en) 2017-05-02 2024-09-17 Georgia Tech Research Corporation Targeted drug delivery methods using a microneedle
AU2019282111C1 (en) * 2018-06-04 2022-08-11 Spermvital As Functionalized kit for preparing hydrogels
KR102315855B1 (ko) * 2018-11-06 2021-10-22 국립암센터 알긴산 기반의 주입형 수화젤 시스템
CN113423386A (zh) * 2019-10-01 2021-09-21 美国倍利年制药有限公司 治疗或预防肥胖和体重管理的方法
JP7801770B2 (ja) * 2020-03-26 2026-01-19 国立大学法人大阪大学 三次元（３ｄ）組織培養用のサポーティングバス
CN114533653B (zh) * 2020-11-26 2023-12-22 上海凯茂生物医药有限公司 一种人促红素杂合Fc融合蛋白相变型制剂及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5416979B2 (de) * 1972-01-08 1979-06-26
US4241099A (en) * 1979-02-26 1980-12-23 Tiemstra Peter J Pectin formulations, products and methods having delayed-action acidulants
US4690682A (en) * 1983-04-15 1987-09-01 Damon Biotech, Inc. Sustained release
US4789516A (en) * 1983-04-15 1988-12-06 Damon Biotech, Inc Production of sustained released system
US4744933A (en) * 1984-02-15 1988-05-17 Massachusetts Institute Of Technology Process for encapsulation and encapsulated active material system
CA1215922A (en) * 1984-05-25 1986-12-30 Connaught Laboratories Limited Microencapsulation of living tissue and cells
JPS645460A (en) * 1987-06-29 1989-01-10 Sanei Kagaku Kogyo Kk Production of delaying gelatinous material
JPH0794583B2 (ja) * 1989-12-15 1995-10-11 株式会社大塚製薬工場 高含水高分子ゲル
IT1245383B (it) * 1991-03-28 1994-09-20 Eniricerche Spa Composizione acquosa gelificabile avente tempo di gelificazione ritardato
US5711968A (en) * 1994-07-25 1998-01-27 Alkermes Controlled Therapeutics, Inc. Composition and method for the controlled release of metal cation-stabilized interferon
KR960006730B1 (ko) * 1993-02-11 1996-05-23 재단법인한국화학연구소 에멀젼 네트웍(emulsion network)을 이용한 약물의 피부 전달체계
GB9708773D0 (en) * 1997-04-30 1997-06-25 Reckitt & Colmann Prod Ltd Organic compositions

Also Published As

Publication number Publication date
HUP0003393A2 (hu) 2001-02-28
NO995591D0 (no) 1999-11-15
PL336887A1 (en) 2000-07-17
BR9809117A (pt) 2000-08-01
DE69838750D1 (de) 2008-01-03
KR20010012374A (ko) 2001-02-15
JP2001525826A (ja) 2001-12-11
PL199565B1 (pl) 2008-10-31
EA199901013A1 (ru) 2000-06-26
BG103914A (en) 2000-07-31
WO1998051348A2 (en) 1998-11-19
HUP0003393A3 (en) 2001-03-28
DE69838750T2 (de) 2008-10-30
EP0981374B1 (de) 2007-11-21
YU58599A (sh) 2000-12-28
SK286437B6 (sk) 2008-10-07
CA2289196C (en) 2007-08-07
CZ299180B6 (cs) 2008-05-14
WO1998051348A3 (en) 1999-02-18
CZ396399A3 (cs) 2000-04-12
EP0981374A2 (de) 2000-03-01
BG64860B1 (bg) 2006-07-31
CA2289196A1 (en) 1998-11-19
ES2294814T3 (es) 2008-04-01
SK154399A3 (en) 2000-07-11
AU7491898A (en) 1998-12-08
IL132814A0 (en) 2001-03-19

Similar Documents

Publication Publication Date Title
NO995591L (no) Geler med forsinket, langvarig frigjörelse
DK1079811T3 (da) Biologisk nedbrydelige alginatgeler med forlænget frigivelse
DE69837140D1 (de) Alginatgele mit verzögerter freisetzung
TR200000782T2 (tr) Resorsinol türevleri.
MXPA02004666A (es) Gelatinas recombinantes.
ID23374A (id) Halogenopirimidin
DE69730202D1 (de) Azidfreie, gaserzeugende zusammensetzungen
ID24703A (id) Kuinolon antimikroba, komposisi dan penggunaannya
MXPA03008714A (es) Polimeros secuenciados y composiciones cosmeticas que comprenden tales polimeros.
TR199800375A3 (tr) Selant kompozisyonlari.
IT1308627B1 (it) Composizioni fluoroelastomeriche.
TR200003390T2 (tr) 2-(2-Metilfenil)-3,4-dihidro-2H-pirol türevleri
TR200003389T2 (tr) 2-(2-klorofenil)-3,4-dihidro-2H-pirol türevleri.
NO20010873L (no) Mikropartikkel-blanding
DE59902827D1 (de) Azidfreie, gaserzeugende Zusammensetzung
ID26611A (id) Turunan-turunan pirol tersubstitusi heteroaril, pembuatannya dan kegunaan-kegunaan terapetiknya
DE69627702D1 (de) Stabilisierte, korrosionsinhibierte feuerhemmende zusammensetzungen und methoden
PT1107793E (pt) Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados
TR199900430T2 (xx) �kameli 1,2,3,4-tetrahidro-2-dibenzofuranaminler ve 2-aminosiklohepta$b] benzofuranlar.
DE60001366D1 (de) Orale zusammensetzung enthaltend perlit
AU6832498A (en) Substituted benzyl oximino compounds
ATE234841T1 (de) Nodulisporinsäurederivate
DE59909590D1 (de) Azidfreie, gaserzeugende zusammensetzung
MXPA03001440A (es) Compuestos de trioxepano novedosos.
DE69908923D1 (de) 1,3,4-thiadiazolylazofarbstoffe-enthaltende tintenzusammensetzungen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application